No Data
InspireMD (NSPR.US) will release its financial report before the market opens on November 12th.
$InspireMD(NSPR.US)$ will release its financial report before the market opens on November 12th. How was the previous performance? $InspireMD(NSPR.US)$ revenue in 2024/Q2 was $1.739 million, net income was -$-7.909 million, and EPS was -$0.22. Revenue in 2023/Q3 was $1.556 million, net income was -$-5.178 million, and EPS was -$0.15. The above data is based on US_GAAP accounting standards. Reminder: 1. Listed on the Hong Kong and U.S. stock markets
Express News | InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12TH
One InspireMD Insider Raised Stake By 13% In Previous Year
InspireMD Announces Establishment of Global Headquarters in Florida
Express News | InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the Cguard Prime Carotid Stent System
InspireMD Advances With FDA Study Approval and Global Goals
